Study tracks COVID-19 antibodies over time (IMAGE)

University of Virginia Health System

Study tracks COVID-19 antibodies over time

Caption

“Both Pfizer/BioNTech and Moderna have proven very effective in protecting against severe disease, but our study builds on others that have shown some subtle differences in outcomes that favor Moderna,” said senior author Jeffrey Wilson, MD, PhD. “This could particularly be true in higher risk populations, such as older subjects or those who have conditions with suppressed immune systems.”

Credit

UVA Health

Usage Restrictions

Can be used to accompany news coverage of the antibody tracking study. All other uses require express written permission from UVA Health.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.